Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 4/20 | 0.66 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.66 |
| ▸ | ECE1 | P42892 | 1/20 | 0.66 |
| ▸ | CPB1 | P15086 | 1/20 | 0.62 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.59 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | SIRT2 | Q8IXJ6 | 3/20 | 0.58 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.58 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.58 |
| ▸ | DPP4 | P27487 | 2/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.57 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15968143 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL6476819 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL287475 | 1.00 | ITGB3 (0.66) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL4994643 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL29733071 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL11310715 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Hydrochloric Acid SCHEMBL21219335 | 0.99 | ITGB3 (0.65) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Monoethanolamine SCHEMBL9496843 | 0.96 | ITGB3 (0.62) | ITGB3ITGA2BECE1CPB1CPB2 | |
| Glycine SCHEMBL28708677 | 0.96 | ITGB3 (0.62) | ITGB3ITGA2BECE1CPB1CPB2 | |
| SCHEMBL2367228 | 0.96 | ITGB3 (0.64) | ITGB3ITGA2BECE1CPB1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121362603-B | Efficient environment-friendly auxiliary agent, preparation method thereof and application thereof in raw gas absorption and oil-water separation | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-121570433-A | Glutamine metabolism regulation nano drug delivery system for enhancing pancreatic cancer targeting and penetration, and preparation method and application thereof | 复旦大学 | 2026-02-27 | — | — | CN | claimed |
| CN-111868079-B | IL-2 variants | 协和麒麟株式会社 | 2025-06-17 | — | — | CN | claimed |
| CN-120136804-A | Glutamic acid-N-carboxyl-cyclic anhydride monomer containing ethyl nitrate group, polymer thereof and application of glutamic acid-N-carboxyl-cyclic anhydride monomer serving as nitric oxide donor | 武汉理工大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120058821-A | Prodrug designed based on tumor LAT1 transporter and preparation method thereof | 广西中医药大学 | 2025-05-30 | — | — | CN | claimed |
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-05-22 | — | — | US | claimed |
| CN-114402200-B | Method for quantifying functional C1 esterase inhibitor (FC 1-INH) | 武田药品工业株式会社 | 2025-04-22 | — | — | CN | claimed |
| WO-2025077788-A1 | TRANSFECTION REAGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海市第六人民医院 | 2025-04-17 | — | — | WO | claimed |
| EP-4533102-A2 | SYSTEMS, COMPOSITIONS AND METHODS FOR IDENTIFYING E3 LIGASE SUBSTRATES BY UBIQUITIN BIOTINYLATION | The Broad Institute, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119732914-A | Nanometer degradation agent based on proteolytic targeting chimeric molecule, preparation method and application thereof | 中国科学院长春应用化学研究所 | 2025-04-01 | — | — | CN | claimed |
| EP-0253303-A2 | Metal chelating resins | F. HOFFMANN-LA ROCHE AG (CH) | 1988-01-20 | — | — | EP | claimed |
| EP-0190058-B1 | PEPTIDE DERIVATIVES WITH A POLYCYCLIC NITROGEN STRUCTURE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ADIR (FR) | 1987-12-23 | — | — | EP | claimed |
| EP-0213996-A1 | Ramified polymers based on lipopeptides forming thermotropic and lyotropic liquid crystals, their use and corresponding monomers | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-11 | — | — | EP | claimed |
| EP-0090100-B1 | INSOLUBLE POLYMERS WITH ANTI-COAGULATING PROPERTIES, ARTICLES CONTAINING THEM AND METHODS OF MANUFACTURE | Fougnot, Christine (FR) | 1986-09-17 | — | — | EP | claimed |
| EP-0190058-A1 | Peptide derivatives with a polycyclic nitrogen structure, process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1986-08-06 | — | — | EP | claimed |
| EP-0023854-B1 | SOLUBLE POLYMERS POSSESSING ANTICOAGULATING PROPERTIES, PROCESS FOR PREPARING THEM AND THEIR USE AS DRUGS WITH ANTICOAGULATING ACTION | Fougnot, Christine (FR) | 1984-12-12 | — | — | EP | claimed |
| EP-0090100-A1 | Insoluble polymers with anti-coagulating properties, articles containing them and methods of manufacture | Fougnot, Christine (FR) | 1983-10-05 | — | — | EP | claimed |
| EP-0085255-A2 | N-acyl peptide, processes for their preparation and pharmaceutical compostions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-08-10 | — | — | EP | claimed |
| EP-0023854-A1 | Soluble polymers possessing anticoagulating properties, process for preparing them and their use as drugs with anticoagulating action | Fougnot, Christine (FR) | 1981-02-11 | — | — | EP | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163003-A1 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | PGM2, DNPEP, NPEPPS | ITGB3 4215/4885ITGA2B 4688/4885ECE1 1671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.